[en] In this interview, we discuss the use of psychedelic drugs as a promising treatment in disorders of consciousness. Psilocybin, a classic psychedelic, is currently undergoing substantial clinical investigations in healthy volunteers, but also in clinical populations. Recently, experts in the field of psychedelics have addressed the attractive possibility to use such psychedelics on patients suffering
from disorders of consciousness. Building on her empirical and theoretical research on disorders of consciousness, Olivia Gosseries gives us her opinion. Implementing rigorous clinical trials with psychedelics on patients with disorders of consciousness will allow their clinical efficacy to be tested. We finish the interview by briefly addressing the ethical and legal challenges and discussing other related non-pathological modified states of consciousness.
Research Center/Unit :
GIGA-Consciousness-Coma Science Group; CHU de Liège - Centre du Cerveau²
Disciplines :
Neurosciences & behavior
Author, co-author :
Gosseries, Olivia ; Université de Liège - ULiège > GIGA-Consciousness-Coma Science Group ; CHU de Liège - Centre du Cerveau²
Martial, Charlotte ; Université de Liège - ULiège > GIGA-Consciousness-Coma Science Group ; CHU de Liège - Centre du Cerveau²
Language :
English
Title :
The Use of Psychedelics in the Treatment of Disorders of Consciousness
Publication date :
January 2021
Main work title :
ALIUS BULLETIN: Exploring the diversity of consciousness (n°4)